DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
FRA:DRW8 - Deutsche Boerse Ag - DE0005550602 - Common Stock - Currency: EUR
DRW8 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of DRW8 get a neutral evaluation. Nothing too spectacular is happening here. DRW8 may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, DRW8 could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
DRW8 had positive earnings in the past year.
In the past year DRW8 had a positive cash flow from operations.
Of the past 5 years DRW8 4 years were profitable.
DRW8 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
DRW8 has a better Return On Assets (3.75%) than 63.64% of its industry peers.
DRW8's Return On Equity of 7.54% is fine compared to the rest of the industry. DRW8 outperforms 63.64% of its industry peers.
DRW8's Return On Invested Capital of 7.13% is fine compared to the rest of the industry. DRW8 outperforms 67.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 7.54% | ||
| ROIC | 7.13% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8 has a Profit Margin (3.42%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DRW8 has grown nicely.
DRW8 has a Operating Margin (5.77%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DRW8 has grown nicely.
DRW8 has a Gross Margin of 44.97%. This is in the lower half of the industry: DRW8 underperforms 61.82% of its industry peers.
In the last couple of years the Gross Margin of DRW8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.77% | ||
| PM (TTM) | 3.42% | ||
| GM | 44.97% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DRW8 is creating some value.
Compared to 1 year ago, DRW8 has less shares outstanding
DRW8 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DRW8 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.59 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.59, DRW8 perfoms like the industry average, outperforming 52.73% of the companies in the same industry.
The Debt to FCF ratio of DRW8 is 2.08, which is a good value as it means it would take DRW8, 2.08 years of fcf income to pay off all of its debts.
DRW8 has a Debt to FCF ratio of 2.08. This is amongst the best in the industry. DRW8 outperforms 81.82% of its industry peers.
DRW8 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
DRW8's Debt to Equity ratio of 0.10 is amongst the best of the industry. DRW8 outperforms 83.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.08 | ||
| Altman-Z | 2.59 |
ROIC/WACC1.14
WACC6.26%
2.3 Liquidity
A Current Ratio of 1.81 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Current ratio of 1.81. This is comparable to the rest of the industry: DRW8 outperforms 52.73% of its industry peers.
A Quick Ratio of 1.12 indicates that DRW8 should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.12, DRW8 perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
DRW8 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.79%, which is quite good.
DRW8 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.42% yearly.
Looking at the last year, DRW8 shows a small growth in Revenue. The Revenue has grown by 0.51% in the last year.
Measured over the past years, DRW8 shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)14.79%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-129.48%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.76%
3.2 Future
DRW8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.55% yearly.
Based on estimates for the next years, DRW8 will show a small growth in Revenue. The Revenue will grow by 2.64% on average per year.
EPS Next Y0.82%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
EPS Next 5Y6.55%
Revenue Next Year3.83%
Revenue Next 2Y3.96%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.30, the valuation of DRW8 can be described as very reasonable.
DRW8's Price/Earnings ratio is rather cheap when compared to the industry. DRW8 is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.04, DRW8 is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.22, the valuation of DRW8 can be described as very reasonable.
98.18% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 37.64. DRW8 is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.3 | ||
| Fwd PE | 8.22 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DRW8 is valued cheaper than 96.36% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.3 | ||
| EV/EBITDA | 2.98 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)11.35
PEG (5Y)0.26
EPS Next 2Y8.16%
EPS Next 3Y10.79%
5. Dividend
5.1 Amount
DRW8 has a Yearly Dividend Yield of 3.44%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.07, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 94.55% of the companies listed in the same industry.
DRW8's Dividend Yield is a higher than the S&P500 average which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.44% |
5.2 History
On average, the dividend of DRW8 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
28.77% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
The dividend of DRW8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.77%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
FRA:DRW8 (7/25/2025, 7:00:00 PM)
57.2
-0.4 (-0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners9.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.07B
Analysts74.67
Price Target72.65 (27.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.44% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP28.77%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.22%
PT rev (3m)12.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.3 | ||
| Fwd PE | 8.22 | ||
| P/S | 0.32 | ||
| P/FCF | 8.3 | ||
| P/OCF | 5.66 | ||
| P/B | 0.7 | ||
| P/tB | 0.9 | ||
| EV/EBITDA | 2.98 |
EPS(TTM)6.15
EY10.75%
EPS(NY)6.95
Fwd EY12.16%
FCF(TTM)6.89
FCFY12.05%
OCF(TTM)10.11
OCFY17.68%
SpS179.39
BVpS81.51
TBVpS63.3
PEG (NY)11.35
PEG (5Y)0.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 7.54% | ||
| ROCE | 9.48% | ||
| ROIC | 7.13% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 10.31% | ||
| OM | 5.77% | ||
| PM (TTM) | 3.42% | ||
| GM | 44.97% | ||
| FCFM | 3.84% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-18.01%
ROICexcg growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.08 | ||
| Debt/EBITDA | 0.45 | ||
| Cap/Depr | 41.06% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 10.18 | ||
| Cash Conversion | 55.59% | ||
| Profit Quality | 112.21% | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 2.59 |
F-Score6
WACC6.26%
ROIC/WACC1.14
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.79%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-129.48%
EPS Next Y0.82%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
EPS Next 5Y6.55%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.76%
Revenue Next Year3.83%
Revenue Next 2Y3.96%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%
EBIT growth 1Y16.32%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.53%
EBIT Next 3Y29.41%
EBIT Next 5Y12.44%
FCF growth 1Y165.3%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y253.6%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%